Michael W. Bonney, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 11,250 shares at $450.00 ($5.1M) on 2025-08-18, disclosed to the SEC on 2025-08-19.
Scheduled sale ($5.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALNY | SELL | 2023-08-04 | $2.2M | — | Filing → |
| BMY | BUY | 2020-06-09 | $5K | — | Filing → |
| SRPT | BUY | 2019-09-09 | $173K | — | Filing → |